Thermo Fisher Scientific阐述药物研发一体化策略的价值

AgilentBoston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat

Thermo FisherTMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Borrow Rate - Xã Thanh Hà

AgilentIs Agilent Technologies a Better Buy Than Danaher? - Trefis

Lonza NewsLonza集团(SWX:LONN)股价近期波动后是否定价过高？-雅虎财经

Thermo Fisher赛默飞世尔科技公司第四季度财报后股价下跌2.95%，尽管每股收益微超预期且营收同比增长3.9%。

FierceBiotech礼来公司放弃与瑞格生物剩余协议，RIPK1抑制剂再遭打击。

Thermo FisherThermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com

WatersWAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La

FierceBiotech麦克森以12.5亿美元将外科部门少数股权置换给阿波罗基金。

FierceBiotechAcuityMD raises $80M to help bolster AI in the medtech industry

FierceBiotechAACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’

FierceBiotechMerck goes with Google for AI push, striking enterprise partnership worth up to $1B